183 related articles for article (PubMed ID: 35415979)
1. The Risk of Internal Malignancy Following a Prior Diagnosis of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients.
Gal N; Didkovsky E; Hodak E; Davidovici BB
Isr Med Assoc J; 2022 Apr; 24(4):219-224. PubMed ID: 35415979
[TBL] [Abstract][Full Text] [Related]
2. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
3. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
4. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma.
Zwald FO; Sargen MR; Austin AA; Hsieh MC; Pawlish K; Li J; Lynch CF; Yu KJ; Engels EA
Am J Transplant; 2024 Jun; 24(6):993-1002. PubMed ID: 38387619
[TBL] [Abstract][Full Text] [Related]
8. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.
Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI
JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post-transplant non-melanoma skin cancer.
Hartmann J; Schüler S; Enk AH; Lonsdorf AS
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1281-1289. PubMed ID: 30811675
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
13. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
14. External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort.
Gómez-Tomás Á; Bouwes Bavinck JN; Genders R; González-Cruz C; de Jong E; Arron S; García-Patos V; Ferrándiz-Pulido C
JAMA Dermatol; 2023 Jan; 159(1):29-36. PubMed ID: 36416811
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
17. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
Veness MJ; Harris D
Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
[TBL] [Abstract][Full Text] [Related]
18. Skin Cancer in Non-White Solid Organ Transplant Recipients: Mayo Clinic Experience.
Zieman D; Heckman M; Brushaber D; Degesys C; Tolaymat L
South Med J; 2023 Oct; 116(10):839-844. PubMed ID: 37788820
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients.
Fania L; Abeni D; Esposito I; Spagnoletti G; Citterio F; Romagnoli J; Castriota M; Ricci F; Moro F; Perino F; Mazzanti C; De Simone C; Peris K
G Ital Dermatol Venereol; 2020 Oct; 155(5):669-675. PubMed ID: 30251802
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
